These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 16962791)
1. In vitro reconstitution and preparative purification of complexes between the chemokine receptor CXCR4 and its ligands SDF-1alpha, gp120-CD4 and AMD3100. Dukkipati A; Vaclavikova J; Waghray D; Garcia KC Protein Expr Purif; 2006 Dec; 50(2):203-14. PubMed ID: 16962791 [TBL] [Abstract][Full Text] [Related]
2. CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection. Klasse PJ; Rosenkilde MM; Signoret N; Pelchen-Matthews A; Schwartz TW; Marsh M J Virol; 1999 Sep; 73(9):7453-66. PubMed ID: 10438835 [TBL] [Abstract][Full Text] [Related]
3. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells. Mbemba E; Benjouad A; Saffar L; Gattegno L Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606 [TBL] [Abstract][Full Text] [Related]
4. Regulation of CXCR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study. Toth PT; Ren D; Miller RJ J Pharmacol Exp Ther; 2004 Jul; 310(1):8-17. PubMed ID: 15014135 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 envelope is a neutral antagonist to CXCR4 in T-cells. Staudinger R; Wang X; Bandrés JC Biochem Biophys Res Commun; 2001 Feb; 280(4):1003-7. PubMed ID: 11162626 [TBL] [Abstract][Full Text] [Related]
6. Synthetic peptides for study of human immunodeficiency virus infection. Dettin M; Scarinci C; Pasquato A; Di Bello C Appl Biochem Biotechnol; 2002; 102-103(1-6):41-7. PubMed ID: 12396109 [TBL] [Abstract][Full Text] [Related]
7. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities. Brelot A; Heveker N; Montes M; Alizon M J Biol Chem; 2000 Aug; 275(31):23736-44. PubMed ID: 10825158 [TBL] [Abstract][Full Text] [Related]
8. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1. Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575 [TBL] [Abstract][Full Text] [Related]
9. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use. Schols D; Esté JA; Cabrera C; De Clercq E J Virol; 1998 May; 72(5):4032-7. PubMed ID: 9557691 [TBL] [Abstract][Full Text] [Related]
11. Solubilization of the chemokine receptor CXCR4. Staudinger R; Bandres JC Biochem Biophys Res Commun; 2000 Jul; 274(1):153-6. PubMed ID: 10903911 [TBL] [Abstract][Full Text] [Related]
12. Comodulation of CXCR4 and CD26 in human lymphocytes. Herrera C; Morimoto C; Blanco J; Mallol J; Arenzana F; Lluis C; Franco R J Biol Chem; 2001 Jun; 276(22):19532-9. PubMed ID: 11278278 [TBL] [Abstract][Full Text] [Related]
13. Spontaneous and ligand-induced trafficking of CXC-chemokine receptor 4. Tarasova NI; Stauber RH; Michejda CJ J Biol Chem; 1998 Jun; 273(26):15883-6. PubMed ID: 9632631 [TBL] [Abstract][Full Text] [Related]
14. The implication of the chemokine receptor CXCR4 in HIV-1 envelope protein-induced apoptosis is independent of the G protein-mediated signalling. Blanco J; Jacotot E; Cabrera C; Cardona A; Clotet B; De Clercq E; Esté JA AIDS; 1999 May; 13(8):909-17. PubMed ID: 10371171 [TBL] [Abstract][Full Text] [Related]
15. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Donzella GA; Schols D; Lin SW; Esté JA; Nagashima KA; Maddon PJ; Allaway GP; Sakmar TP; Henson G; De Clercq E; Moore JP Nat Med; 1998 Jan; 4(1):72-7. PubMed ID: 9427609 [TBL] [Abstract][Full Text] [Related]
16. Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12). Veldkamp CT; Seibert C; Peterson FC; Sakmar TP; Volkman BF J Mol Biol; 2006 Jun; 359(5):1400-9. PubMed ID: 16725153 [TBL] [Abstract][Full Text] [Related]
17. Differential level in co-down-modulation of CD4 and CXCR4 primed by HIV-1 gp120 in response to phorbol ester, PMA, among HIV-1 isolates. Tahara-Hanaoka S; Ushijima Y; Tarui H; Wada M; Hara T; Imanishi S; Yamaguchi T; Hattori T; Nakauchi H; Koito A Microbiol Immunol; 2000; 44(6):489-98. PubMed ID: 10941932 [TBL] [Abstract][Full Text] [Related]
19. N-linked glycosylation in the CXCR4 N-terminus inhibits binding to HIV-1 envelope glycoproteins. Wang J; Babcock GJ; Choe H; Farzan M; Sodroski J; Gabuzda D Virology; 2004 Jun; 324(1):140-50. PubMed ID: 15183061 [TBL] [Abstract][Full Text] [Related]
20. Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes. Lazarini F; Casanova P; Tham TN; De Clercq E; Arenzana-Seisdedos F; Baleux F; Dubois-Dalcq M Eur J Neurosci; 2000 Jan; 12(1):117-25. PubMed ID: 10651866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]